tiprankstipranks
Trending News
More News >

Rapid Micro Biosystems initiated with an Overweight at KeyBanc

KeyBanc initiated coverage of Rapid Micro Biosystems (RPID) with an Overweight rating and $8 price target The analyst believes Rapid Micro’s Microbial Growth Direct System is “changing the paradigm” in biological manufacturing quality control. The system is more accurate and provides digital results in three to five days versus manual methods in 5-14 days, the analyst tells investors in a research note. KeyBanc says Rapid Micro is gaining wide adoption in the biopharmaceutical industry that will increase sales visibility and improve margins.

Don’t Miss TipRanks’ Half-Year Sale

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1